Amgen Inc. (NASDAQ:AMGN) Q4 2023 Earnings Call Transcript
Amgen Inc. beats earnings expectations. Reported EPS is $4.71, expectations were $4.66.
Stay updated with breaking news from Peter Griffith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amgen Inc. beats earnings expectations. Reported EPS is $4.71, expectations were $4.66.
Amgen is focused on price declines while it looks to fill out its portfolio and chase the new obesity market.
Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase in revenue following the biotechnology company's October acquisition of rare disease drugmaker...
(Reuters) -Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase in revenue following the biotechnology company's October acquisition of rare disease drugmaker Horizon Therapeutics. For full-year 2024, the company said it expects adjusted earnings per share of $18.90 to $20.30 on revenue of $32.4 billion to $33.8 billion. "The guidance looks good and in line with consensus," Jefferies analyst Michael Yee said in an email.
(Reuters) -Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase in revenue following the biotechnology company's October acquisition of rare disease drugmaker Horizon Therapeutics. For full-year 2024, the company said it expects adjusted earnings per share of $18.90 to $20.30 on revenue of $32.4 billion to $33.8 billion. "The guidance looks good and in line with consensus," Jefferies analyst Michael Yee said in an email.